1. Home
  2. KEQU vs MOLN Comparison

KEQU vs MOLN Comparison

Compare KEQU & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEQU
  • MOLN
  • Stock Information
  • Founded
  • KEQU 1906
  • MOLN 2004
  • Country
  • KEQU United States
  • MOLN Switzerland
  • Employees
  • KEQU N/A
  • MOLN N/A
  • Industry
  • KEQU Medical Specialities
  • MOLN
  • Sector
  • KEQU Industrials
  • MOLN
  • Exchange
  • KEQU Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • KEQU 183.3M
  • MOLN 192.4M
  • IPO Year
  • KEQU N/A
  • MOLN 2021
  • Fundamental
  • Price
  • KEQU $64.80
  • MOLN $5.04
  • Analyst Decision
  • KEQU
  • MOLN
  • Analyst Count
  • KEQU 0
  • MOLN 0
  • Target Price
  • KEQU N/A
  • MOLN N/A
  • AVG Volume (30 Days)
  • KEQU 21.6K
  • MOLN 5.7K
  • Earning Date
  • KEQU 03-05-2025
  • MOLN 03-13-2025
  • Dividend Yield
  • KEQU N/A
  • MOLN N/A
  • EPS Growth
  • KEQU 168.79
  • MOLN N/A
  • EPS
  • KEQU 6.31
  • MOLN N/A
  • Revenue
  • KEQU $199,637,000.00
  • MOLN $7,105,397.00
  • Revenue This Year
  • KEQU N/A
  • MOLN N/A
  • Revenue Next Year
  • KEQU N/A
  • MOLN $29.41
  • P/E Ratio
  • KEQU $9.84
  • MOLN N/A
  • Revenue Growth
  • KEQU N/A
  • MOLN N/A
  • 52 Week Low
  • KEQU $27.00
  • MOLN $3.32
  • 52 Week High
  • KEQU $67.20
  • MOLN $12.70
  • Technical
  • Relative Strength Index (RSI)
  • KEQU 57.72
  • MOLN 41.97
  • Support Level
  • KEQU $57.58
  • MOLN $5.22
  • Resistance Level
  • KEQU $65.00
  • MOLN $5.35
  • Average True Range (ATR)
  • KEQU 2.48
  • MOLN 0.12
  • MACD
  • KEQU -0.25
  • MOLN -0.03
  • Stochastic Oscillator
  • KEQU 68.59
  • MOLN 0.00

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: